Steven Feldman to Drug Utilization
This is a "connection" page, showing publications Steven Feldman has written about Drug Utilization.
Connection Strength
2.658
-
Nolan BV, Levender MM, Davis SA, Feneran AN, Fleischer AB, Feldman SR. Trends in the use of topical over the counter products in the management of dermatologic disease in the United States. Dermatol Online J. 2012 Feb 15; 18(2):1.
Score: 0.401
-
Lapolla WJ, Levender MM, Davis SA, Yentzer BA, Williford PM, Feldman SR. Topical antibiotic trends from 1993 to 2007: use of topical antibiotics for non-evidence-based indications. Dermatol Surg. 2011 Oct; 37(10):1427-33.
Score: 0.388
-
Ghasri P, Yentzer BA, Dabade TS, Feldman SR. Acitretin for the treatment of psoriasis: an assessment of national trends. J Drugs Dermatol. 2011 Aug; 10(8):873-7.
Score: 0.386
-
Strowd LC, Yentzer BA, Fleischer AB, Feldman SR. Increasing use of more potent treatments for psoriasis. J Am Acad Dermatol. 2009 Mar; 60(3):478-81.
Score: 0.321
-
Pearce DJ, Stealey KH, Balkrishnan R, Fleischer AB, Feldman SR. Psoriasis treatment in the United States at the end of the 20th century. Int J Dermatol. 2006 Apr; 45(4):370-4.
Score: 0.267
-
Balkrishnan R, Kulkarni AS, Cayce K, Feldman SR. Predictors of healthcare outcomes and costs related to medication use in patients with acne in the United States. Cutis. 2006 Apr; 77(4):251-5.
Score: 0.267
-
He A, Feldman SR, Fleischer AB. An assessment of the use of antihistamines in the management of atopic dermatitis. J Am Acad Dermatol. 2018 Jul; 79(1):92-96.
Score: 0.151
-
Mireku K, Huang KE, Narahari S, Davis SA, Feldman SR. Psoriasis treatments by payment type in the US outpatient office setting. J Drugs Dermatol. 2013 Oct; 12(10):1095-7.
Score: 0.112
-
Lin HC, Lucas PT, Feldman SR, Balkrishnan R. Medication use and associated health care outcomes and costs for patients with psoriasis in the United States. J Dermatolog Treat. 2012 Jun; 23(3):196-202.
Score: 0.093
-
Balkrishnan R, Bhosle MJ, Camacho F, Fleischer AB, Feldman SR. Prescribing patterns for topical retinoids: analyses of 15 years of data from the national ambulatory medical care survey. J Dermatolog Treat. 2010 May; 21(3):193-200.
Score: 0.089
-
Balkrishnan R, Cayce KA, Kulkarni AS, Orsagh T, Gallagher JR, Richmond D, Feldman SR. Predictors of treatment choices and associated outcomes in actinic keratoses: results from a national physician survey study. J Dermatolog Treat. 2006; 17(3):162-6.
Score: 0.066
-
Fleischer AB, Simpson JK, McMichael A, Feldman SR. Are there racial and sex differences in the use of oral isotretinoin for acne management in the United States? J Am Acad Dermatol. 2003 Oct; 49(4):662-6.
Score: 0.056
-
Alghanem N, Abokwidir M, Fleischer AB, Feldman SR, Alghanem W. Variation in cash price of the generic medications most prescribed by dermatologists in pharmacies across the United States. J Dermatolog Treat. 2017 Mar; 28(2):119-128.
Score: 0.034
-
Thevarajah S, Balkrishnan R, Camacho FT, Feldman SR, Fleischer AB. Trends in prescription of acne medication in the US: shift from antibiotic to non-antibiotic treatment. J Dermatolog Treat. 2005; 16(4):224-8.
Score: 0.015
-
Railan D, Wilson JK, Feldman SR, Fleischer AB. Pediatricians who prescribe clotrimazole-betamethasone diproprionate (Lotrisone) often utilize it in inappropriate settings regardless of their knowledge of the drug's potency. Dermatol Online J. 2002 Oct; 8(2):3.
Score: 0.013